Darwin Advisors, LLC Dexcom Inc Transaction History

Darwin Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Aug 15, 2025	BUY	$67.74 - $90.75 $1,693 - $2,268	25 New	25 $1,000
Q4 2024 Aug 29, 2025	BUY	$65.68 - $81.01 $1,642 - $2,025	25 New	25 $1,000
Q4 2024 Aug 15, 2025	BUY	$65.68 - $81.01 $1,642 - $2,025	25 New	25 $1,000
Q3 2024 Nov 08, 2024	BUY	$64.0 - $116.06 $1,600 - $2,901	25 New	25 $1,000
Q3 2020 Oct 16, 2020	SELL	$95.51 - $112.95 $750,135 - $887,109	-7,854 Closed	0 $0

Q2 2020 Aug 06, 2020	BUY	$62.68 - $105.34 $484,140 - $813,646	7,724 Added 5941.54%	7,854 $3.18 Million
Q1 2020 May 01, 2020	BUY	$47.79 - $75.63 $6,212 - $9,831	130 New	130 $35,000

1,086

376M

6.76M

7.24M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Darwin Advisors, LLC with notifications on news.